FSE$FMS
Fresenius Medical Care AG & Co. KGAA · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
Fresenius Medical Care reported modest revenue growth and a significant decline in net income in Q4 2024.
Fresenius Medical Care posted Q4 2024 revenue of €5.09 billion, reflecting a 2% year-over-year increase. Operating income fell 39% to €259 million due to portfolio optimization impacts, while net income dropped 64% to €67 million. The Care Enablement segment drove growth, increasing revenue by 11%, while Care Delivery revenue declined by 1% due to divestitures. Free cash flow improved by 25% to €599 million, supporting deleveraging efforts.
- Total revenue grew 2% year-over-year to €5.09 billion, led by the Care Enablement segment.
- Operating income declined 39% to €259 million due to one-time portfolio optimization effects.
- Net income dropped 64% to €67 million, impacted by lower operating profit and restructuring costs.
- Free cash flow increased by 25% to €599 million, supporting financial deleveraging efforts.
Headline financials
Revenue & EPS history
Fresenius Medical Care · Revenue · Quarterly
$5.28B
Forward guidance
Fresenius Medical Care expects low single-digit revenue growth and high-teens to high-twenties percent earnings growth in 2025.
Tailwinds
- Revenue growth expected to be positive in the low-single-digit range.
- Operating income projected to grow in the high-teens to high-twenties percent range.
- FME25 transformation program savings target raised to €750 million.
- Care Enablement expected to continue strong volume growth momentum.
- Further deleveraging expected with continued strong cash generation.
Headwinds
- Portfolio optimization may continue to weigh on short-term revenue growth.
- Higher personnel and operational costs could pressure operating margins.
- Unfavorable foreign exchange impacts may create headwinds on earnings.
- Ongoing restructuring costs associated with transformation initiatives.
- Potential uncertainties in reimbursement rates and regulatory changes.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+0.1%
Avg return
Earnings day
-1.3%
Avg return
5 days after
+0.2%
Avg return
30 days after
16%
11 / 67 earnings
Positive
+23.1%
Q1 2011
Best reaction
-8.9%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -6.7% | -1.3% | +55.7% | |
| Q4 2024 | +0.0% | +3.9% | +5.3% | |
| Q2 2024 | +0.0% | -6.4% | -4.9% | |
| Q4 2023 | +6.7% | -8.2% | -9.7% | |
| Q3 2023 | +0.0% | +2.0% | +24.6% | |
| Q2 2023 | +0.0% | +0.2% | -7.9% | |
| Q1 2023 | -0.5% | +1.3% | +0.2% | |
| Q4 2022 | +6.9% | +0.0% | +1.6% | |
| Q3 2022 | +0.0% | +7.9% | +11.3% | |
| Q2 2022 | +0.0% | -18.6% | -24.4% | |
| Q1 2022 | -8.9% | -4.7% | -9.3% | |
| Q4 2021 | +0.0% | -2.1% | -2.5% | |
| Q3 2021 | -4.6% | +4.3% | -10.8% | |
| Q2 2021 | +0.0% | -3.2% | -5.7% | |
| Q1 2021 | +0.0% | -1.0% | +3.6% | |
| Q4 2020 | +0.0% | -3.1% | +3.5% | |
| Q3 2020 | +0.0% | -2.5% | +6.5% | |
| Q2 2020 | +0.0% | -4.9% | -9.2% | |
| Q1 2020 | +0.0% | +2.9% | +13.6% | |
| Q4 2019 | +3.1% | -4.2% | -28.6% | |
| Q3 2019 | +3.3% | +10.5% | +10.8% | |
| Q2 2019 | -8.8% | -10.1% | -11.5% | |
| Q1 2019 | +6.7% | -1.8% | -12.6% | |
| Q4 2018 | +0.0% | +3.8% | +0.5% | |
| Q3 2018 | -1.9% | -2.8% | +4.0% | |
| Q2 2018 | +0.0% | +0.9% | +8.3% | |
| Q1 2018 | +0.0% | -2.5% | -3.6% | |
| Q4 2017 | -2.5% | -5.8% | -6.7% | |
| Q3 2017 | -0.5% | +0.2% | +2.6% | |
| Q2 2017 | +0.0% | -1.3% | -0.1% | |
| Q1 2017 | +0.0% | +1.5% | +6.7% | |
| Q4 2016 | +0.0% | +0.8% | +1.8% | |
| Q3 2016 | +0.0% | +0.5% | -2.5% | |
| Q2 2016 | +2.6% | +1.0% | -4.5% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | +1.1% | — | — | |
| Q3 2015 | +5.4% | — | — | |
| Q2 2015 | -4.7% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +7.0% | — | — | |
| Q3 2014 | +0.0% | — | — | |
| Q2 2014 | -4.5% | — | — | |
| Q1 2014 | +0.0% | — | — | |
| Q4 2012 | -6.4% | — | — | |
| Q4 2013 | -6.4% | — | — | |
| Q3 2013 | +0.0% | — | — | |
| Q2 2013 | -3.7% | — | — | |
| Q1 2013 | +0.0% | — | — | |
| Q3 2012 | +0.0% | — | — | |
| Q2 2012 | +0.0% | — | — | |
| Q1 2012 | -0.6% | — | — | |
| Q4 2011 | +1.4% | — | — | |
| Q3 2011 | +0.0% | — | — | |
| Q2 2011 | +0.0% | — | — | |
| Q1 2011 | +23.1% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q1 2010 | +0.0% | — | — | |
| Q1 2009 | +0.0% | — | — | |
| Q4 2009 | +0.0% | — | — | |
| Q4 2007 | +0.0% | — | — | |
| Q3 2008 | +0.0% | — | — | |
| Q3 2009 | +0.0% | — | — | |
| Q2 2008 | +0.0% | — | — | |
| Q4 2008 | +0.0% | — | — | |
| Q2 2009 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro